Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
Newsletter
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
TXG
10x Genomics
Saxonov Serge
/
director, officer: Chief Executive Officer
09/14/2023
Sell
$49.82
80
$4K
862,093
NASDAQ
TXG
10x Genomics
Saxonov Serge
/
director, officer: Chief Executive Officer
09/14/2023
Sell
$49.35
1,920
$95K
862,173
NASDAQ
ABEO
Abeona Therapeutics
O'Malley Brendan M.
/
officer: SVP, General Counsel
09/18/2023
Buy
$3.80
3,000
$11K
187,421
NASDAQ
ABEO
Abeona Therapeutics
Vazzano Joseph Walter
/
officer: Chief Financial Officer
09/19/2023
Buy
$3.70
14
$52
235,193
NASDAQ
ABEO
Abeona Therapeutics
Vazzano Joseph Walter
/
officer: Chief Financial Officer
09/19/2023
Buy
$3.82
2,986
$11K
238,179
NASDAQ
ACAD
Acadia Pharmaceuticals
Kihara James
/
officer: Principal Accounting Officer
09/15/2023
Sell
$25.88
2,000
$52K
10,778
NASDAQ
ACCD
Accolade
SINGH RAJEEV
/
director, officer: Chief Executive Officer
09/19/2023
Sell
$11.81
378
$4K
586,630
NASDAQ
ACCD
Accolade
Barnes Stephen H.
/
officer: Chief Financial Officer
09/19/2023
Sell
$11.81
121
$1K
144,019
NASDAQ
ACCD
Accolade
Cavanaugh Robert N
/
officer: President
09/19/2023
Sell
$11.81
157
$2K
166,378
NASDAQ
ADVM
Adverum Biotechnologies
Seyedkazemi Setareh
/
officer: Chief Development Officer
09/15/2023
Sell
$1.55
130
$201
47,674
NASDAQ
ADVM
Adverum Biotechnologies
Seyedkazemi Setareh
/
officer: Chief Development Officer
09/15/2023
Sell
$1.52
6,071
$9K
47,804
NYSE
AGTI
Agiliti
Leonard Thomas J
/
director
09/19/2023
Sell
$7.26
15,000
$109K
938,564
NYSE
AGTI
Agiliti
Leonard Thomas J
/
director
09/20/2023
Sell
$7.12
27,558
$196K
966,122
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
09/01/2023
Sell
$50.24
127
$6K
462,680
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
09/01/2023
Sell
$49.77
24,873
$1.238M
462,807
NASDAQ
ALHC
Alignment Health
JOYCE CHRISTOPHER J
/
officer: Chief Legal and Admin. Officer
09/13/2023
Sell
$5.20
15,474
$80K
267,834
NASDAQ
TKNO
Alpha Teknova
Telegraph Hill Partners IV, L.P.
/
10 percent owner
09/19/2023
Buy
$1.85
1.19M
$2.202M
3.76M
NASDAQ
TKNO
Alpha Teknova
Telegraph Hill Partners IV, L.P.
/
10 percent owner
09/19/2023
Buy
$1.85
6.92M
$12.798M
21.86M
NASDAQ
TKNO
Alpha Teknova
Gunstream Stephen
/
director, officer: President and CEO
09/19/2023
Buy
$1.85
54,054
$100K
162,852
NASDAQ
TKNO
Alpha Teknova
Lowell Matthew
/
officer: Chief Financial Officer
09/19/2023
Buy
$1.85
54,054
$100K
88,054
NASDAQ
TKNO
Alpha Teknova
MACKOWSKI J MATTHEW
/
director
09/19/2023
Buy
$1.85
810,810
$1.500M
810,810
NASDAQ
TKNO
Alpha Teknova
Terrill Damon
/
officer: General Counsel and CCO
09/19/2023
Buy
$1.85
27,027
$50K
41,027
NASDAQ
ATEC
Alphatec
Miles Patrick
/
director, officer: CEO
09/20/2023
Sell
$13.35
60,000
$801K
5.63M
NASDAQ
ATEC
Alphatec
Miles Patrick
/
director, officer: CEO
09/19/2023
Sell
$13.42
60,000
$805K
5.69M
NASDAQ
ATEC
Alphatec
Miles Patrick
/
director, officer: CEO
09/18/2023
Sell
$13.48
60,000
$809K
5.75M
NASDAQ
AMAM
Ambrx Biopharma
Cormorant Asset Management, LP
/
10 percent owner
09/15/2023
Buy
$9.05
1.40M
$12.681M
68.71M
NASDAQ
AMAM
Ambrx Biopharma
Cormorant Asset Management, LP
/
10 percent owner
09/18/2023
Buy
$9.24
751,233
$6.945M
69.47M
NASDAQ
AMGN
Amgen
AMGEN INC
/
10 percent owner
09/19/2023
Buy
$17.00
1.76M
$30.000M
35.37M
NASDAQ
FOLD
Amicus Therapeutics
Crowley John F
/
director, officer: Executive Chairman
09/15/2023
Sell
$13.06
6,044
$79K
914,009
NASDAQ
ANTX
AN2 Therapeutics
Adjuvant Global Health Technology Fund, L.P.
/
10 percent owner
09/13/2023
Sell
$16.00
64
$1K
411,893
NASDAQ
ANTX
AN2 Therapeutics
Adjuvant Global Health Technology Fund, L.P.
/
10 percent owner
09/13/2023
Sell
$16.00
336
$5K
2.18M
NASDAQ
ANTX
AN2 Therapeutics
Aziz Kabeer
/
director, 10 percent owner:
09/13/2023
Sell
$16.00
64
$1K
411,893
NASDAQ
ANTX
AN2 Therapeutics
Aziz Kabeer
/
director, 10 percent owner:
09/13/2023
Sell
$16.00
336
$5K
2.18M
NASDAQ
ANAB
AnaptysBio
MULROY DENNIS
/
officer: Chief Financial Officer
09/18/2023
Sell
$19.32
3,895
$75K
964
NASDAQ
ANAB
AnaptysBio
MULROY DENNIS
/
officer: Chief Financial Officer
09/14/2023
Sell
$19.48
2,105
$41K
4,859
NASDAQ
ANAB
AnaptysBio
LOUMEAU ERIC J
/
officer: Chief Legal Officer
09/18/2023
Sell
$19.32
3,895
$75K
882
NASDAQ
ANAB
AnaptysBio
LOUMEAU ERIC J
/
officer: Chief Legal Officer
09/14/2023
Sell
$19.48
2,105
$41K
4,777
NASDAQ
ANAB
AnaptysBio
Lizzul Paul F.
/
officer: Chief Medical Officer
09/14/2023
Sell
$19.48
2,105
$41K
6,527
NASDAQ
ANIP
ANI Pharmaceuticals
Shanmugam Muthusamy
/
director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/18/2023
Sell
$61.64
8,425
$519K
1.11M
NASDAQ
ANIP
ANI Pharmaceuticals
Shanmugam Muthusamy
/
director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/15/2023
Sell
$62.81
16,242
$1.020M
1.12M
NASDAQ
ANIP
ANI Pharmaceuticals
Shanmugam Muthusamy
/
director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/19/2023
Sell
$61.23
25,333
$1.551M
1.08M
NASDAQ
APLS
Apellis Pharmaceuticals
Machiels Alec
/
director
09/15/2023
Sell
$45.34
1,250
$57K
367,420
NASDAQ
APLS
Apellis Pharmaceuticals
Machiels Alec
/
director
09/18/2023
Sell
$45.00
1,250
$56K
367,420
NASDAQ
APLS
Apellis Pharmaceuticals
Nicholson Nur
/
officer: Chief Technical Officer
09/18/2023
Sell
$46.15
10,631
$491K
53,284
NASDAQ
APLS
Apellis Pharmaceuticals
Nicholson Nur
/
officer: Chief Technical Officer
09/18/2023
Sell
$42.21
9,719
$410K
63,915
NASDAQ
ARWR
Arrowhead Pharmaceuticals
Anzalone Christopher Richard
/
director, officer: Chief Executive Officer
09/18/2023
Sell
$28.27
26,232
$742K
3.76M
NASDAQ
ARWR
Arrowhead Pharmaceuticals
Anzalone Christopher Richard
/
director, officer: Chief Executive Officer
09/18/2023
Sell
$28.00
31,523
$883K
3.79M
TSX.V
ASG
Aurora Spine
MILAS ROBERT
/
09/18/2023
Buy
$5.02
500
$3K
500
NASDAQ
AXSM
Axsome Therapeutics
Coleman Mark
/
director
09/15/2023
Sell
$75.19
11,016
$828K
25,097
NASDAQ
AXSM
Axsome Therapeutics
Coleman Mark
/
director
09/15/2023
Sell
$75.18
18,572
$1.396M
403,856
NASDAQ
BRTX
BioRestorative Therapies
ALSTODT LANCE
/
director, 10 percent owner, officer: President, CEO, COB
09/15/2023
Buy
$1.70
2,200
$4K
189,505
NASDAQ
BRTX
BioRestorative Therapies
Broadrick Dale
/
10 percent owner
09/14/2023
Buy
$1.54
10,000
$15K
317,573
NASDAQ
BRTX
BioRestorative Therapies
Broadrick Dale
/
10 percent owner
09/15/2023
Buy
$1.66
10,000
$17K
327,573
NYSE
BSX
Boston Scientific
Carruthers Wendy
/
officer: EVP, Human Resources
09/15/2023
Sell
$53.95
11,671
$630K
57,058
NYSE
BSX
Boston Scientific
Fitzgerald Joseph Michael
/
officer: EVP & Group Pres, Cardiology
09/20/2023
Sell
$55.00
15,867
$873K
197,992
NYSE
BHG
Bright Health
Yang Rick
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
Chang Carmen
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
Florence Anthony A. Jr.
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
Mathers Edward T
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
SANDELL SCOTT D
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
NEA 18 Venture Growth Equity, L.P.
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
Walker Paul Edward
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NYSE
BHG
Bright Health
Behbahani Ali
/
10 percent owner
09/15/2023
Buy
$0.01
552,263
$6K
1.38M
NASDAQ
CABA
Cabaletta Bio
Binder Gwendolyn
/
officer: See Remarks
09/19/2023
Sell
$17.50
10,300
$180K
20,700
NASDAQ
CABA
Cabaletta Bio
Binder Gwendolyn
/
officer: See Remarks
09/19/2023
Sell
$18.50
700
$13K
20,000
NASDAQ
CING
Cingulate
Callahan Jennifer L.
/
officer: Corporate Controller
09/15/2023
Buy
$0.67
5,000
$3K
45,508
NYSE
CNMD
CONMED
Peters Stanley W III
/
officer: President AS and AET
09/13/2023
Sell
$107.32
2,000
$215K
63
NASDAQ
CORT
Corcept Therapeutics
Robb Gary Charles
/
officer: Chief Business Officer
09/19/2023
Sell
$32.74
5,000
$164K
21,996
NASDAQ
CORT
Corcept Therapeutics
Maduck Sean
/
officer: See Remarks
09/19/2023
Sell
$32.48
25,000
$812K
73,610
NASDAQ
CBAY
CymaBay Therapeutics
Quinlan Paul T
/
officer: General Counsel
09/15/2023
Sell
$16.87
24,000
$405K
0
NASDAQ
CBAY
CymaBay Therapeutics
Quinlan Paul T
/
officer: General Counsel
09/15/2023
Sell
$16.87
5,000
$84K
0
NASDAQ
CBAY
CymaBay Therapeutics
Menold Daniel
/
officer: Vice President, Finance
09/15/2023
Sell
$16.87
0
$0
0
NASDAQ
CBAY
CymaBay Therapeutics
McWherter Charles
/
officer: President of R&D
09/18/2023
Sell
$16.22
21,746
$353K
15,000
NASDAQ
CBAY
CymaBay Therapeutics
Quinlan Paul T
/
officer: General Counsel
09/15/2023
Sell
$16.87
24,000
$405K
0
NASDAQ
CTKB
Cytek Biosciences
Yan Ming
/
director, officer: Chief Technology Officer
09/19/2023
Sell
$6.49
20,000
$130K
7.80M
NASDAQ
DNLI
Denali Therapeutics
SATO VICKI L
/
director
09/15/2023
Sell
$24.35
40
$974
129,705
NASDAQ
DNLI
Denali Therapeutics
SATO VICKI L
/
director
09/15/2023
Sell
$23.60
1,626
$38K
129,745
NASDAQ
DXCM
DexCom
ALTMAN STEVEN R
/
director
09/15/2023
Sell
$101.50
1,000
$101K
61,700
NASDAQ
DCGO
DocGo
Bienstock Lee
/
officer: Chief Executive Officer
09/15/2023
Sell
$6.32
1,667
$11K
300,704
NASDAQ
DCGO
DocGo
Tendler Ely D
/
director, officer: General Counsel and Secretary
09/15/2023
Sell
$5.91
10,000
$59K
23,088
NASDAQ
DYN
Dyne Therapeutics
Beskrovnaya Oxana
/
officer: Chief Scientific Officer
09/18/2023
Sell
$9.41
1,436
$14K
84,334
NASDAQ
DYN
Dyne Therapeutics
HIGH SUSANNA GATTI
/
officer: Chief Operating Officer
09/18/2023
Sell
$9.41
2,672
$25K
104,544
NASDAQ
DYN
Dyne Therapeutics
Brumm Joshua T
/
director, officer: See Remarks
09/18/2023
Sell
$9.41
12,032
$113K
233,679
NASDAQ
DYN
Dyne Therapeutics
McNeill Jonathan
/
officer: Chief Business Officer
09/18/2023
Sell
$9.41
1,261
$12K
60,605
NASDAQ
DYN
Dyne Therapeutics
Scalzo Richard William
/
officer: See Remarks
09/18/2023
Sell
$9.41
1,290
$12K
40,795
NYSE
EW
Edwards Lifesciences
Wood Larry L
/
officer: Global President TAVR & Surg
09/14/2023
Sell
$73.63
8,660
$638K
213,793
NYSE
EW
Edwards Lifesciences
BOBO DONALD E JR
/
officer: CVP,Strategy/Corp Development
09/14/2023
Sell
$73.71
4,500
$332K
39,502
NASDAQ
ECOR
electroCore
Goldberger Daniel S
/
director, officer: Chief Executive Officer
09/15/2023
Buy
$5.56
1,500
$8K
136,060
NASDAQ
TRDA
Entrada Therapeutics
Doshi Dipal
/
director, officer: President and CEO
09/13/2023
Sell
$15.00
1,000
$15K
248,279
NASDAQ
ENVB
Enveric Biosciences
PASQUALONE FRANK
/
director
09/15/2023
Buy
$2.14
1,000
$2K
1,000
NASDAQ
ESPR
Esperion Therapeutics
Warren Eric
/
officer: Chief Commercial Officer
09/20/2023
Sell
$1.25
742
$924
68,318
NASDAQ
EYEN
Eyenovia
Rowe Michael M
/
director, officer: Chief Executive Officer
09/15/2023
Buy
$1.75
1,137
$2K
26,637
NASDAQ
EYEN
Eyenovia
Rowe Michael M
/
director, officer: Chief Executive Officer
09/19/2023
Buy
$1.66
1,400
$2K
28,037
NASDAQ
FWBI
First Wave BioPharma
CASAMENTO CHARLES J
/
director
09/15/2023
Sell
$0.43
10
$4
6,098
NASDAQ
GNLX
Genelux
Thomas John
/
director
09/15/2023
Sell
$22.38
1,088
$24K
479,127
NASDAQ
GNLX
Genelux
Yu Yong
/
officer: VP, Clinical Trial Operations
09/13/2023
Sell
$21.14
29,800
$630K
106,135
NASDAQ
GNLX
Genelux
Yu Yong
/
officer: VP, Clinical Trial Operations
09/20/2023
Sell
$27.96
6,000
$168K
106,135
NASDAQ
GNLX
Genelux
Ryder Sean
/
officer: General Counsel
09/20/2023
Sell
$30.00
10,000
$300K
572
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/14/2023
Sell
$22.31
13,871
$310K
35,292
NASDAQ
GNLX
Genelux
Thomas John
/
director
09/15/2023
Sell
$21.67
2,245
$49K
480,215
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/19/2023
Sell
$27.16
8,247
$224K
0
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/14/2023
Sell
$21.77
11,405
$248K
49,163
NASDAQ
GNLX
Genelux
Yu Yong
/
officer: VP, Clinical Trial Operations
09/15/2023
Sell
$22.29
4,675
$104K
106,135
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/18/2023
Sell
$24.17
2,927
$71K
5,000
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/13/2023
Sell
$22.31
3,315
$74K
60,568
NASDAQ
GNLX
Genelux
Yu Yong
/
officer: VP, Clinical Trial Operations
09/15/2023
Sell
$21.56
5,725
$123K
110,810
NASDAQ
GNLX
Genelux
Smither John W
/
director
09/13/2023
Sell
$20.78
900
$19K
6,920
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/18/2023
Sell
$23.20
27,365
$635K
7,927
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/13/2023
Sell
$21.26
15,717
$334K
63,883
NASDAQ
GNLX
Genelux
Thomas John
/
director
09/18/2023
Sell
$24.99
3,334
$83K
475,793
NASDAQ
GNLX
Genelux
Szalay Aladar
/
10 percent owner
09/19/2023
Sell
$26.21
23,920
$627K
8,247
NYSE
DNA
Ginkgo Bioworks
Shetty Reshma P.
/
director, 10 percent owner, officer: See remarks
09/14/2023
Sell
$2.00
37,650
$75K
12.90M
NYSE
DNA
Ginkgo Bioworks
Kelly Jason R
/
director, officer: See remarks
09/14/2023
Sell
$2.00
100,000
$200K
6.89M
NYSE
DNA
Ginkgo Bioworks
Shetty Reshma P.
/
director, 10 percent owner, officer: See remarks
09/13/2023
Sell
$2.04
37,650
$77K
12.90M
NYSE
DNA
Ginkgo Bioworks
Kelly Jason R
/
director, officer: See remarks
09/13/2023
Sell
$2.04
100,000
$204K
6.99M
NYSE
DNA
Ginkgo Bioworks
Canton Barry
/
10 percent owner
09/14/2023
Sell
$2.00
37,650
$75K
12.90M
NYSE
DNA
Ginkgo Bioworks
Canton Barry
/
10 percent owner
09/13/2023
Sell
$2.04
37,650
$77K
12.90M
NASDAQ
GLSI
Greenwich LifeSciences
Patel Snehal
/
director, 10 percent owner, officer: CEO and CFO
09/19/2023
Buy
$8.95
4,000
$36K
5.30M
NASDAQ
HROW
Harrow Health
Opaleye Management Inc.
/
10 percent owner
09/19/2023
Buy
$14.65
14,017
$205K
3.61M
NASDAQ
HROW
Harrow Health
Opaleye Management Inc.
/
10 percent owner
09/20/2023
Buy
$14.49
5,983
$87K
3.62M
NASDAQ
HCWB
HCW Biologics
Winer Gary M
/
director
09/13/2023
Buy
$2.00
46
$92
15,959
NASDAQ
HCWB
HCW Biologics
Winer Gary M
/
director
09/14/2023
Buy
$2.08
162
$337
16,121
NASDAQ
HCWB
HCW Biologics
Winer Gary M
/
director
09/14/2023
Buy
$2.05
879
$2K
17,000
NASDAQ
HCWB
HCW Biologics
Byam Rebecca
/
officer: Chief Financial Officer
09/13/2023
Buy
$2.10
5,000
$10K
573,946
NASDAQ
HCWB
HCW Biologics
Winer Gary M
/
director
09/13/2023
Buy
$2.05
500
$1K
15,913
NASDAQ
HCWB
HCW Biologics
Wong Hing C
/
director, officer: Chief Executive Officer
09/14/2023
Buy
$2.08
1,800
$4K
15.31M
NASDAQ
HCAT
Health Catalyst
Llewelyn Linda
/
officer: Chief People Officer
09/15/2023
Sell
$11.01
1,160
$13K
80,892
NASDAQ
BEAT
HeartBeam
de Urioste George
/
director
09/18/2023
Sell
$2.46
5,000
$12K
59,839
NASDAQ
BEAT
HeartBeam
de Urioste George
/
director
09/13/2023
Sell
$1.95
3,122
$6K
74,108
NASDAQ
BEAT
HeartBeam
de Urioste George
/
director
09/15/2023
Sell
$2.43
4,269
$10K
64,839
NASDAQ
BEAT
HeartBeam
de Urioste George
/
director
09/13/2023
Sell
$1.90
1,878
$4K
77,230
NASDAQ
BEAT
HeartBeam
de Urioste George
/
director
09/14/2023
Sell
$2.17
5,000
$11K
69,108
NASDAQ
HEPA
Hepion Pharmaceuticals
Wijngaard Peter
/
director
09/15/2023
Buy
$5.37
861
$5K
3,501
NASDAQ
HEPA
Hepion Pharmaceuticals
Wijngaard Peter
/
director
09/19/2023
Buy
$5.64
1,000
$6K
4,501
NASDAQ
HEPA
Hepion Pharmaceuticals
Foster Robert T
/
director, officer: CEO and Director
09/18/2023
Buy
$5.60
1,600
$9K
50,470
NASDAQ
HEPA
Hepion Pharmaceuticals
Wijngaard Peter
/
director
09/15/2023
Buy
$5.82
1,000
$6K
2,501
NASDAQ
HEPA
Hepion Pharmaceuticals
Foster Robert T
/
director, officer: CEO,CSO and Director
09/15/2023
Buy
$5.40
1,600
$9K
48,870
NASDAQ
HEPA
Hepion Pharmaceuticals
Wijngaard Peter
/
director
09/15/2023
Buy
$5.45
139
$758
2,640
NASDAQ
HUMA
Humacyte
Dougan Brady W
/
director
09/14/2023
Sell
$2.78
2.00M
$5.560M
6.19M
NASDAQ
HUMA
Humacyte
Niklason Laura E
/
director, officer: President, CEO and Director
09/14/2023
Sell
$2.78
2.00M
$5.560M
6.19M
NASDAQ
IMMX
Immix Biopharma
Hsu Jason
/
director
09/11/2023
Buy
$2.89
25,000
$72K
710,000
NASDAQ
IMMX
Immix Biopharma
Hsu Jason
/
director
09/12/2023
Buy
$2.83
30,000
$85K
740,000
NASDAQ
IMMX
Immix Biopharma
Hsu Jason
/
director
09/14/2023
Buy
$2.58
10,000
$26K
750,000
NASDAQ
IMMX
Immix Biopharma
Hsu Jason
/
director
09/15/2023
Buy
$2.49
7,000
$17K
757,000
NASDAQ
IMMX
Immix Biopharma
Ng Carey
/
director
09/14/2023
Buy
$2.58
10,000
$26K
10,000
NASDAQ
IMGN
ImmunoGen
Wingrove Theresa
/
officer: SVP OF REGULATORY AFFAIRS
09/15/2023
Sell
$15.44
192,013
$2.965M
2,811
NASDAQ
INAB
IN8bio
Graff Jeremy R.
/
director
09/13/2023
Buy
$0.95
2,500
$2K
2,500
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
09/15/2023
Sell
$67.58
100
$7K
1.02M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
09/15/2023
Sell
$66.95
6,671
$447K
1.02M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
09/15/2023
Sell
$66.27
3,229
$214K
1.03M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
09/15/2023
Sell
$67.05
7,901
$530K
1.03M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
09/15/2023
Sell
$66.40
7,099
$471K
1.04M
NASDAQ
PODD
Insulet
Singh Prem
/
officer: SVP, Global Operations
09/19/2023
Buy
$168.92
1
$169
4,032
NASDAQ
ITCI
Intra-Cellular Therapies
Mates Sharon
/
director, officer: Chairman, President & CEO
09/18/2023
Sell
$53.55
27,468
$1.471M
1.12M
NASDAQ
ITCI
Intra-Cellular Therapies
Mates Sharon
/
director, officer: Chairman, President & CEO
09/19/2023
Sell
$54.17
44,413
$2.406M
1.05M
NASDAQ
ITCI
Intra-Cellular Therapies
Mates Sharon
/
director, officer: Chairman, President & CEO
09/18/2023
Sell
$53.96
28,119
$1.517M
1.09M
NASDAQ
ISRG
Intuitive Surgical
Ladd Amy L
/
director
09/14/2023
Sell
$305.68
500
$153K
702
NASDAQ
IOVA
Iovance Biotherapeutics
Rothbaum Wayne P.
/
director
09/15/2023
Buy
$5.30
5.00M
$26.500M
23.07M
NASDAQ
IOVA
Iovance Biotherapeutics
MCPEAK MERRILL A
/
director
09/18/2023
Buy
$5.56
10,000
$56K
248,633
NYSE
IQV
IQVIA
Panagos Constantinos
/
officer: See Remarks
09/19/2023
Sell
$208.69
19,898
$4.153M
14,250
NYSE
IQV
IQVIA
Panagos Constantinos
/
officer: See Remarks
09/19/2023
Sell
$208.63
7,419
$1.548M
33,017
NASDAQ
IRMD
IRadimed
Susi Roger E.
/
director, 10 percent owner, officer: CEO, PRESIDENT, CHAIRMAN
09/19/2023
Sell
$45.69
5,000
$228K
302,950
NASDAQ
IRMD
IRadimed
Susi Roger E.
/
director, 10 percent owner, officer: CEO, PRESIDENT, CHAIRMAN
09/18/2023
Sell
$46.11
5,000
$231K
307,950
NASDAQ
IRWD
Ironwood Pharmaceuticals
Emany Sravan Kumar
/
officer: SVP, Chief Financial Officer
09/15/2023
Buy
$8.32
36,072
$300K
188,730
NASDAQ
ISPC
iSpecimen
Bielak Benjamin
/
officer: Chief Info Officer & Secretary
09/14/2023
Buy
$0.72
18,000
$13K
84,348
NASDAQ
KA
Kineta
PHILIPS CRAIG W.
/
officer: President
09/20/2023
Buy
$2.54
600
$2K
54,911
NASDAQ
KA
Kineta
Baker Keith
/
officer: Chief Financial Officer
09/18/2023
Buy
$2.13
5,000
$11K
16,880
NASDAQ
KA
Kineta
PHILIPS CRAIG W.
/
officer: President
09/21/2023
Buy
$2.40
2,900
$7K
57,811
NASDAQ
KA
Kineta
Guillaudeux Thierry
/
officer: Chief Scientific Officer
09/14/2023
Buy
$2.00
10,000
$20K
21,696
NASDAQ
KA
Kineta
Bartoszek Raymond J.
/
director
09/19/2023
Buy
$2.37
2,000
$5K
14,956
NASDAQ
KA
Kineta
Bartoszek Raymond J.
/
director
09/15/2023
Buy
$2.18
500
$1K
10,456
NASDAQ
KA
Kineta
Iadonato Shawn
/
director, officer: Chief Executive Officer
09/20/2023
Buy
$2.50
10,000
$25K
670,230
NASDAQ
KA
Kineta
Bartoszek Raymond J.
/
director
09/18/2023
Buy
$2.08
2,500
$5K
12,956
NASDAQ
KA
Kineta
Kenny Pauline
/
officer: General Counsel & Secretary
09/20/2023
Buy
$2.58
1,500
$4K
18,448
NASDAQ
LNTH
Lantheus
Niedzwiecki Daniel
/
officer: See Remarks
09/15/2023
Sell
$66.43
2,846
$189K
66,295
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
09/19/2023
Sell
$6.51
75
$488
53,637
NASDAQ
MGTA
Magenta Therapeutics
Fairmount Funds Management LLC
/
director, 10 percent owner:
09/19/2023
Buy
$13.20
30,000
$396K
1.87M
TSX.V
MRVL
Marvel Biosciences
Koopmans Chris
/
officer: EVP, Chief Operations Officer
09/15/2023
Sell
$55.57
2,000
$111K
134,737
TSX.V
MRVL
Marvel Biosciences
MURPHY MATTHEW J
/
director, officer: Chair of Board, President, CEO
09/14/2023
Sell
$55.96
30,000
$1.679M
885,245
NASDAQ
MEDP
Medpace
Medpace Investors, LLC
/
10 percent owner
09/18/2023
Sell
$274.76
53,385
$14.668M
6.18M
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
09/19/2023
Sell
$259.66
137,379
$35.672M
6.04M
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
09/18/2023
Sell
$274.76
53,385
$14.668M
6.18M
NASDAQ
MEDP
Medpace
Medpace Investors, LLC
/
10 percent owner
09/21/2023
Sell
$244.27
61,655
$15.060M
5.91M
NASDAQ
MEDP
Medpace
Medpace Investors, LLC
/
10 percent owner
09/20/2023
Sell
$255.48
65,653
$16.773M
5.98M
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
09/21/2023
Sell
$244.27
61,655
$15.060M
5.91M
NASDAQ
MEDP
Medpace
Medpace Investors, LLC
/
10 percent owner
09/19/2023
Sell
$259.66
137,379
$35.672M
6.04M
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
09/20/2023
Sell
$255.48
65,653
$16.773M
5.98M
NASDAQ
MIRM
Mirum Pharmaceuticals
GREY MICHAEL G
/
director
09/14/2023
Sell
$32.00
14,216
$455K
0
NASDAQ
MIRM
Mirum Pharmaceuticals
Heron Patrick J
/
director
09/13/2023
Buy
$31.02
2,625
$81K
159,053
NASDAQ
MRNA
Moderna
Hoge Stephen
/
officer: President
09/15/2023
Sell
$112.99
15,000
$1.695M
1.57M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$114.32
100
$11K
2.22M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$108.21
4,281
$463K
2.23M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$113.22
250
$28K
2.22M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$112.17
900
$101K
2.22M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$111.23
3,895
$433K
2.22M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$110.26
1,400
$154K
2.23M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
09/13/2023
Sell
$108.77
4,174
$454K
2.23M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
director, 10 percent owner:
09/13/2023
Buy
$28.66
29,396
$842K
2.68M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
director, 10 percent owner:
09/13/2023
Buy
$29.25
96,441
$2.821M
2.78M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
director, 10 percent owner:
09/15/2023
Buy
$34.13
47,216
$1.611M
2.83M
NASDAQ
MODV
ModivCare
Sampson L Heath
/
director, officer: President, CEO
09/15/2023
Buy
$34.57
3,500
$121K
27,966
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
director, 10 percent owner:
09/15/2023
Buy
$35.25
152,801
$5.386M
2.98M
NASDAQ
MODV
ModivCare
Coliseum Capital Management, LLC
/
director, 10 percent owner:
09/15/2023
Buy
$35.70
4,362
$156K
2.98M
NASDAQ
NKTR
Nektar Therapeutics
Ajer Jeffrey Robert
/
director
09/18/2023
Sell
$0.69
4,359
$3K
34,153
NASDAQ
NKTR
Nektar Therapeutics
Curet Myriam
/
director
09/18/2023
Sell
$0.69
4,359
$3K
27,418
NASDAQ
NBSE
NeuBase Therapeutics
Symetryx Corp
/
10 percent owner
09/18/2023
Sell
$1.19
50,000
$60K
0
NASDAQ
NBSE
NeuBase Therapeutics
Symetryx Corp
/
10 percent owner
09/15/2023
Sell
$1.26
103,337
$130K
50,000
NASDAQ
NBSE
NeuBase Therapeutics
Symetryx Corp
/
10 percent owner
09/14/2023
Sell
$1.44
129,108
$186K
153,337
NASDAQ
NXGL
NEXGEL
Henry Scott Robert
/
director
09/12/2023
Buy
$2.28
4,000
$9K
105,538
NASDAQ
NXGL
NEXGEL
Henry Scott Robert
/
director
09/13/2023
Buy
$2.25
6,000
$13K
111,538
NASDAQ
NXGL
NEXGEL
Henry Scott Robert
/
director
09/14/2023
Buy
$2.27
500
$1K
112,038
NASDAQ
NUVL
Nuvalent
Miller Deborah Ann
/
officer: Chief Legal Officer
09/15/2023
Sell
$47.99
756
$36K
0
NASDAQ
NUVL
Nuvalent
Miller Deborah Ann
/
officer: Chief Legal Officer
09/15/2023
Sell
$47.43
1,244
$59K
756
NASDAQ
OLMA
Olema Oncology
Myles David C.
/
officer: CH. DISCOV. & NON-CLIN DEV OFF
09/19/2023
Sell
$12.67
20,000
$253K
572,011
NASDAQ
OPTN
OptiNose
Marino Michael F III
/
officer: Chief Legal Officer & Corp Sec
09/18/2023
Sell
$1.37
4,991
$7K
334,699
NASDAQ
OPTN
OptiNose
Mahmoud Ramy A
/
director, officer: Chief Executive Officer
09/18/2023
Sell
$1.37
11,083
$15K
514,729
NYSE
OWLT
Owlet
Workman Kurt
/
director, officer: President & CEO
09/18/2023
Sell
$3.80
1,117
$4K
206,040
NYSE
OWLT
Owlet
Scolnick Kathryn R.
/
officer: Chief Financial Officer
09/18/2023
Sell
$3.80
358
$1K
97,110
NASDAQ
PIII
P3 Health Partners
Chicago Pacific Founders UGP III, LLC
/
10 percent owner
09/11/2023
Buy
$2.52
90,000
$227K
50.12M
NASDAQ
PALI
Palisade Bio
Trenschel Robert J.
/
director
09/14/2023
Sell
$0.64
300
$192
0
NASDAQ
PKBO
Peak Bio
Huh Hoyoung
/
director, 10 percent owner:
09/19/2023
Buy
$0.21
50,000
$10K
8.31M
NASDAQ
PKBO
Peak Bio
Huh Hoyoung
/
director, 10 percent owner:
09/20/2023
Buy
$0.19
30,000
$6K
8.34M
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
09/18/2023
Sell
$19.79
26
$515
7,832
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
09/18/2023
Sell
$19.71
38
$749
7,858
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
09/18/2023
Sell
$19.59
66
$1K
7,896
NYSE
PHR
Phreesia
Gunzburg Janet
/
officer: Principal Accounting Officer
09/18/2023
Sell
$19.79
125
$2K
40,995
NASDAQ
PSTV
Plus Therapeutics
Clowes Howard
/
director
09/13/2023
Buy
$1.43
6,993
$10K
11,693
NASDAQ
PMVP
PMV Pharmaceuticals
Jalota Deepika
/
officer: Chief Development Officer
09/15/2023
Sell
$6.62
4,104
$27K
29,946
NASDAQ
PMVP
PMV Pharmaceuticals
Alland Leila
/
officer: Chief Medical Officer
09/15/2023
Sell
$6.62
6,291
$42K
45,909
NYSE
PBH
Prestige Healthcare
Fritz Mary Beth
/
officer: SVP Quality & Regulatory
09/14/2023
Sell
$58.92
2,540
$150K
15,934
NASDAQ
PRVA
Privia Health
Sullivan William M
/
director
09/15/2023
Sell
$24.40
5,233
$128K
5.52M
NASDAQ
PRVA
Privia Health
Sullivan William M
/
director
09/15/2023
Sell
$25.29
12,920
$327K
5.51M
NASDAQ
PROK
ProKidney
Palihapitiya Chamath
/
10 percent owner
09/19/2023
Sell
$5.47
1.70M
$9.299M
2.07M
NASDAQ
PRTA
Prothena
Walker Karin L
/
officer: Chief Accounting Officer
09/19/2023
Sell
$52.36
5,000
$262K
0
NASDAQ
PRTC
PureTech Health
PureTech Health plc
/
10 percent owner
09/20/2023
Buy
$0.05
0
$0
0
NASDAQ
PYXS
Pyxis Oncology
Sullivan Lara
/
director, officer: President and CEO
09/18/2023
Sell
$2.10
8,541
$18K
2.40M
NASDAQ
PYXS
Pyxis Oncology
Sullivan Lara
/
director, officer: President and CEO
09/14/2023
Sell
$2.25
100
$225
2.41M
NASDAQ
RETA
Reata Pharmaceuticals
Loewen Andrea
/
officer: SVP, Global Regulatory Affairs
09/14/2023
Sell
$172.03
3,175
$546K
28,416
NASDAQ
RXRX
Recursion
Secora Michael
/
officer: Chief Financial Officer
09/12/2023
Sell
$8.43
25,000
$211K
875,686
NASDAQ
RXRX
Recursion
Secora Michael
/
officer: Chief Financial Officer
09/13/2023
Sell
$8.69
25,000
$217K
888,186
NASDAQ
RXRX
Recursion
Borgeson Blake
/
director
09/19/2023
Sell
$8.36
8,885
$74K
7.44M
NASDAQ
RXRX
Recursion
Virani Shafique
/
officer: Chief Business Officer
09/15/2023
Sell
$8.66
18,000
$156K
140,351
NYSE
RMD
ResMed
Farrell Michael J.
/
officer: Chief Executive Officer
09/15/2023
Sell
$146.35
5,675
$831K
449,360
NASDAQ
REVB
Revelation Biosciences
TIDMARSH GEORGE F
/
director
09/18/2023
Sell
$0.74
4,000
$3K
39,348
NASDAQ
REVB
Revelation Biosciences
TIDMARSH GEORGE F
/
director
09/15/2023
Sell
$0.73
9,500
$7K
43,348
NASDAQ
REVB
Revelation Biosciences
TIDMARSH GEORGE F
/
director
09/14/2023
Sell
$0.75
12,000
$9K
52,848
NASDAQ
RVMD
Revolution Medicines
Horn Margaret A
/
officer: Chief Operating Officer
09/15/2023
Sell
$32.08
5,000
$160K
99,474
NASDAQ
RVMD
Revolution Medicines
Anders Jack
/
officer: Chief Financial Officer
09/18/2023
Sell
$31.31
1,427
$45K
53,667
NASDAQ
RVMD
Revolution Medicines
Cislini Jeff
/
officer: General Counsel
09/18/2023
Sell
$31.31
1,214
$38K
42,013
NASDAQ
RVMD
Revolution Medicines
GOLDSMITH MARK A
/
director, officer: See Remarks
09/18/2023
Sell
$31.31
8,054
$252K
349,332
NASDAQ
RVMD
Revolution Medicines
Kelsey Stephen Michael
/
officer: See Remarks
09/18/2023
Sell
$31.31
2,060
$65K
290,388
NASDAQ
RVMD
Revolution Medicines
Horn Margaret A
/
officer: Chief Operating Officer
09/18/2023
Sell
$31.31
2,514
$79K
96,960
NASDAQ
RCKT
Rocket Pharmaceuticals
RTW INVESTMENTS, LP
/
director, 10 percent owner:
09/15/2023
Buy
$0.01
3.13M
$31K
3.13M
NASDAQ
SRRK
Scholar Rock
Qatanani Mo
/
officer: SVP AND HEAD OF RESEARCH
09/18/2023
Sell
$6.34
1,945
$12K
97,043
NASDAQ
VANI
Second Sight Medical
Williams Gregg
/
director, 10 percent owner:
09/14/2023
Buy
$0.95
35,036
$33K
118,483
NASDAQ
VANI
Second Sight Medical
Williams Gregg
/
director, 10 percent owner:
09/18/2023
Buy
$0.96
66,743
$64K
185,226
NASDAQ
SRTS
Sensus Healthcare
Sardano Joseph C
/
director, officer: CHIEF EXECUTIVE OFFICER
09/14/2023
Buy
$2.88
10,000
$29K
1.18M
NASDAQ
SWAV
ShockWave Medical
Godshall Douglas Evan
/
director, officer: President & CEO
09/15/2023
Sell
$210.38
1,200
$252K
150,449
NASDAQ
SWAV
ShockWave Medical
Godshall Douglas Evan
/
director, officer: President & CEO
09/15/2023
Sell
$214.52
500
$107K
141,649
NASDAQ
SWAV
ShockWave Medical
WATKINS FRANK T
/
director
09/20/2023
Sell
$209.23
3,000
$628K
1,532
NASDAQ
SWAV
ShockWave Medical
Godshall Douglas Evan
/
director, officer: President & CEO
09/15/2023
Sell
$213.65
4,871
$1.041M
142,149
NASDAQ
SWAV
ShockWave Medical
Godshall Douglas Evan
/
director, officer: President & CEO
09/15/2023
Sell
$212.74
2,086
$444K
147,020
NASDAQ
SWAV
ShockWave Medical
Godshall Douglas Evan
/
director, officer: President & CEO
09/15/2023
Sell
$211.79
1,343
$284K
149,106
NASDAQ
SPRO
Spero Therapeutics
HAMED KAMAL
/
officer: Chief Medical Officer
09/13/2023
Sell
$1.27
39,496
$50K
576,461
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
09/21/2023
Buy
$39.62
154,814
$6.133M
9.26M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
09/19/2023
Buy
$40.89
4,490
$184K
8.98M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
09/20/2023
Buy
$40.67
132,079
$5.372M
9.11M
NYSEAMEX
STXS
Stereotaxis
Isaac Paul J
/
director
09/14/2023
Buy
$1.65
7,168
$12K
2.64M
NYSEAMEX
STXS
Stereotaxis
Isaac Paul J
/
director
09/15/2023
Buy
$1.63
16,000
$26K
2.65M
NASDAQ
TTOO
T2 Biosystems
CR Group L.P.
/
10 percent owner
09/19/2023
Sell
$0.37
4.16M
$1.522M
15.17M
NASDAQ
TTOO
T2 Biosystems
CR Group L.P.
/
10 percent owner
09/19/2023
Sell
$0.37
831,943
$304K
3.03M
NASDAQ
TTOO
T2 Biosystems
CR Group L.P.
/
10 percent owner
09/19/2023
Sell
$0.37
2.59M
$948K
9.45M
NASDAQ
TTOO
T2 Biosystems
CR Group L.P.
/
10 percent owner
09/19/2023
Sell
$0.37
2.82M
$1.032M
10.29M
NASDAQ
TNDM
Tandem Diabetes Care
McGroddy-Goetz Kathleen
/
director
09/15/2023
Buy
$21.45
1,000
$21K
9,032
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/18/2023
Buy
$9.38
13,544
$127K
3.69M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/18/2023
Buy
$9.49
10,417
$99K
3.70M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/19/2023
Buy
$9.40
95
$893
3.70M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/20/2023
Buy
$9.49
6,923
$66K
3.70M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/14/2023
Buy
$8.94
21,381
$191K
3.64M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/20/2023
Buy
$9.50
15,743
$149K
3.72M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/14/2023
Buy
$9.29
24,716
$230K
3.67M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/21/2023
Buy
$9.48
5,179
$49K
3.72M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/15/2023
Buy
$9.47
7,378
$70K
3.67M
NASDAQ
JYNT
The Joint
Bandera Partners LLC
/
10 percent owner
09/21/2023
Buy
$9.60
212,922
$2.043M
3.94M
NASDAQ
TBPH
Theravance Biopharma
GRAHAM RICHARD A
/
officer: SVP, RESEARCH & DEVELOPMENT
09/14/2023
Sell
$9.89
2,482
$25K
336,803
TSX.V
THRM
Therma Bright
Barkas Rafael
/
officer: SVP, Global Ops & Supply Chain
09/15/2023
Sell
$57.10
2,300
$131K
14,755
TSX.V
THRM
Therma Bright
Stocker Thomas
/
officer: SVP, GM Glo Pneu Comf & BPS
09/15/2023
Sell
$56.81
3,000
$170K
8,950
NASDAQ
QURE
uniQure
Dolmetsch Ricardo
/
officer: President, R&D
09/18/2023
Sell
$7.46
5,841
$44K
163,404
NASDAQ
UTHR
United Therapeutics
Mesa Nilda
/
director
09/13/2023
Sell
$222.36
383
$85K
6,303
NASDAQ
UBX
Unity Biotechnology
Ghosh Anirvan
/
director, officer: Chief Executive Officer
09/14/2023
Sell
$2.47
1,246
$3K
82,222
NYSE
VEEV
Veeva Systems
Wallach Matthew J
/
director
09/18/2023
Sell
$208.34
2,395
$499K
31,340
NYSE
VEEV
Veeva Systems
Wallach Matthew J
/
director
09/18/2023
Sell
$211.24
100
$21K
28,735
NYSE
VEEV
Veeva Systems
Wallach Matthew J
/
director
09/18/2023
Sell
$210.16
263
$55K
28,835
NYSE
VEEV
Veeva Systems
Wallach Matthew J
/
director
09/18/2023
Sell
$209.61
2,242
$470K
29,098
NASDAQ
VTYX
Ventyx Biosciences
Subramaniam Somu
/
director, 10 percent owner:
09/18/2023
Sell
$37.81
56,665
$2.143M
8.49M
NASDAQ
VTYX
Ventyx Biosciences
NSV Partners III LP
/
10 percent owner
09/18/2023
Sell
$37.81
56,665
$2.143M
8.49M
NASDAQ
VSTM
Verastem
Stuglik Brian M
/
director
09/18/2023
Sell
$9.91
478
$5K
91,485
NASDAQ
VSTM
Verastem
Paterson Dan
/
director, officer: President and CEO
09/19/2023
Sell
$9.84
183
$2K
87,343
NASDAQ
VSTM
Verastem
Paterson Dan
/
director, officer: President and CEO
09/18/2023
Sell
$9.91
240
$2K
87,526
NASDAQ
VSTM
Verastem
Gagnon Robert E.
/
director
09/19/2023
Sell
$9.84
130
$1K
46,626
NASDAQ
VSTM
Verastem
Gagnon Robert E.
/
director
09/18/2023
Sell
$9.91
278
$3K
46,756
NASDAQ
VSTM
Verastem
Stuglik Brian M
/
director
09/19/2023
Sell
$9.84
274
$3K
91,211
NASDAQ
VRTX
Vertex Pharmaceuticals
Bozic Carmen
/
officer: EVP and CMO
09/19/2023
Sell
$351.00
5,651
$1.984M
51,905
NASDAQ
VYGR
Voyager Therapeutics
Carter Todd Alfred
/
officer: Chief Scientific Officer
09/15/2023
Sell
$8.16
10,500
$86K
54,360
NYSE
ZTS
Zoetis
Chen Heidi C.
/
officer: Executive Vice President
09/15/2023
Sell
$180.15
9,905
$1.784M
27,478
NYSE
ZTS
Zoetis
Lagano Roxanne
/
officer: Executive Vice President
09/18/2023
Sell
$179.58
923
$166K
24,511
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
Sector Heat Map
List of All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
News From The FDA
Leadership Changes
Popular Topics
Top Stocks in 2023
Artificial Intelligence
Alzheimer's Disease
Big Pharma Stocks
Big Med Stocks
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
About Us
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Health Stock News
Register
or
Login
to Access Entire Platform.
×
Invest in Early Stage Biotech Opportunities
Explore venture capital investment opportunities in the healthcare industry and gain direct access to deal flows
Private placement shares can generally be purchased at a discount to market prices and have purchase warrants attached to them
If the underlying share price rises, warrants can be exercised to further build positions and enhance gains
Hold periods are typically restricted to one year
Sign up to receive notifications of future early-stage investment opportunities:
Are You An Accredited Investor?
Yes
No
Unsure
Investment Consideration Size
< 10,000
10,000 - 50,000
50,000 - 100,000
100,000 +
I agree to
Disclaimer
and
Privacy Policy
.
Submit
Success! You will now receive future alerts.
Check your email inbox now for the most recent version of our daily newsletter and expect exciting future early-stage venture opportunities to come.
Next
Website